Edesa Biotech ROCE
Qual é o ROCE de Edesa Biotech?
O ROCE de Edesa Biotech, Inc. é -241.62%
Qual é a definição de ROCE?
O retorno sobre o capital empregado (ROCE) é um índice financeiro que mede a lucratividade de uma empresa e a eficiência com que seu capital é usado.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de empresas na Setor Health Care em NASDAQ em comparação com Edesa Biotech
O que Edesa Biotech faz?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas com roce semelhantes a Edesa Biotech
- BioXcel Therapeutics Inc tem ROCE de -245.99%
- Verrica Pharmaceuticals Inc tem ROCE de -244.95%
- Shift Technologies tem ROCE de -244.72%
- Qumu Corp tem ROCE de -244.21%
- Bellerophon Therapeutics Inc tem ROCE de -243.25%
- Chesapeake tem ROCE de -242.92%
- Edesa Biotech tem ROCE de -241.62%
- Vermillion tem ROCE de -241.19%
- LadRx Corp tem ROCE de -241.02%
- Mvp Hldgs Inc New tem ROCE de -240.98%
- Stellar AfricaGold tem ROCE de -240.24%
- BigDish Plc tem ROCE de -239.87%
- Titan Medical Inc tem ROCE de -239.26%